Safe Orthopaedics entered into distribution agreements covering Mexico and Chile.
Here are four key points:
1. Safe Orthopaedics' products have received marketing approval for the Chilean market.
2. Mexico is currently reviewing the company's application for marketing approval, which Safe Orthopaedics expects to receive by the fourth quarter of 2016.
3. Safe Orthopaedics received regulatory approval for its SteriSpine ranges in Australia and New Zealand earlier this year.
4. The France-based medical technology company develops and markets a range of sterile implants and associated single-use surgical instruments.